Send this to a friend

Boston Scientific acquires U.K. pancreatic cancer firm

Marlborough medical device maker Boston Scientific has acquired a privately-held British firm that has developed a device to help treat pancreatic cancer.
The acquisition of EMcision, Ltd., was announced Monday, but the terms were not disclosed.
Both companies released the news Monday morning, with EMcision calling Boston Scientific the world’s premier endoscopic devices company.

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media